James Investment Research Inc Haemonetics Corp Transaction History

James Investment Research Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	SELL	$72.75 - $90.6 $12,294 - $15,311	-169 Reduced 22.3%	589 $49,000
Q4 2022 Jan 30, 2023	SELL	$73.85 - $86.14 $83,819 - $97,768	-1,135 Reduced 59.96%	758 $60,000
Q3 2022 Oct 31, 2022	BUY	$63.3 - $78.66 $119,826 - $148,903	1,893 New	1,893 $140,000

340

53.4M

543K

306K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $2.68B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

Stay updated on James Investment Research Inc with notifications on news.